These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22027319)

  • 1. Comparison of clinically relevant technical attributes of five insulin injection pens.
    Asakura T
    J Diabetes Sci Technol; 2011 Sep; 5(5):1203-9. PubMed ID: 22027319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Injection force of reusable insulin pens: Novopen 4, Lilly Luxura, Berlipen, and ClikSTAR.
    Friedrichs A; Korger V; Adler S
    J Diabetes Sci Technol; 2011 Sep; 5(5):1185-90. PubMed ID: 22027315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose accuracy of the ClikSTAR, NovoPen 4, and Luxura insulin pens: results of laboratory and field studies.
    Friedrichs A; Basso N; Adler S
    J Diabetes Sci Technol; 2011 Sep; 5(5):1179-84. PubMed ID: 22027314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of 25 years' experience with the NovoPen family of insulin pens in the management of diabetes mellitus.
    Hyllested-Winge J; Jensen KH; Rex J
    Clin Drug Investig; 2010; 30(10):643-74. PubMed ID: 20701399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of dose selection attributes with audible notification in insulin pen devices.
    Asakura T; Seino H
    Diabetes Technol Ther; 2005 Aug; 7(4):620-6. PubMed ID: 16120036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novopen Echo® for the delivery of insulin: a comparison of usability, functionality and preference among pediatric subjects, their parents, and health care professionals.
    Olsen BS; Lilleøre SK; Korsholm CN; Kracht T
    J Diabetes Sci Technol; 2010 Nov; 4(6):1468-75. PubMed ID: 21129343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of a new reusable insulin pen.
    Penfornis A
    Diabetes Technol Ther; 2011 Mar; 13(3):373-9. PubMed ID: 21291331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Insulin Underdelivery from Prefilled and Reusable Insulin Pens in Cases of Premature Needle Withdrawal: A Laboratory Evaluation.
    Joubert M; Haddouche A; Morera J; Rod A; Reznik Y
    Diabetes Technol Ther; 2015 Oct; 17(10):712-6. PubMed ID: 26355757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FlexTouch® for the delivery of insulin: technical attributes and perception among patients and healthcare professionals.
    Bailey T; Campos C
    Expert Rev Med Devices; 2012 May; 9(3):209-17. PubMed ID: 22471783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis: desirable attributes of insulin injection pens that drive patient preference and compliance.
    Zahn JD
    J Diabetes Sci Technol; 2011 Sep; 5(5):1210-1. PubMed ID: 22027320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Half-Unit Insulin Pens: Disease Management in Patients With Diabetes Who Are Sensitive to Insulin.
    Klonoff DC; Nayberg I; Stauder U; Oualali H; Domenger C
    J Diabetes Sci Technol; 2017 May; 11(3):623-630. PubMed ID: 27898389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient acceptance and issues of education of two durable insulin pen devices.
    Asakura T; Seino H; Jensen KH
    Diabetes Technol Ther; 2008 Aug; 10(4):299-304. PubMed ID: 18715204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new durable insulin pen with memory function among people with diabetes and healthcare professionals.
    Guo X; Sommavilla B; Vanterpool G; Qvist M; Bethien M; Lilleøre SK
    Expert Opin Drug Deliv; 2012 Apr; 9(4):355-6. PubMed ID: 22432521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, open-label, comparative crossover handling trial between two durable pens in patients with type 1 or 2 diabetes mellitus.
    Sommavilla B; Pietranera G
    J Diabetes Sci Technol; 2011 Sep; 5(5):1212-21. PubMed ID: 22027321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiating insulin therapy in type 2 diabetes: benefits of insulin analogs and insulin pens.
    Brunton S
    Diabetes Technol Ther; 2008 Aug; 10(4):247-56. PubMed ID: 18715198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the NovoPen® Echo for the delivery of insulin: a comparison of usability, functionality, and preference among pediatric subjects, their parents, and health care professionals.
    Reynholds C; Antal Z
    J Diabetes Sci Technol; 2010 Nov; 4(6):1476-8. PubMed ID: 21129344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trigger matters: an ergonomy analysis of insulin pens.
    Fendler W; Roman-Liu D; Tokarski T; Romanczuk R; Mlynarski W
    Diabetes Technol Ther; 2015 Mar; 17(3):171-6. PubMed ID: 25607378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prefilled insulin pen with a novel injection mechanism and a lower injection force than other prefilled insulin pens.
    Hemmingsen H; Niemeyer M; Hansen MR; Bucher D; Thomsen NB
    Diabetes Technol Ther; 2011 Dec; 13(12):1207-11. PubMed ID: 21864019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of injection force and dosage scale size between NovoPen 3 and NovoPen 4.
    Donsmark M; Herold L; Kristensen CM
    Diabetes Technol Ther; 2009 Sep; 11(9):581-5. PubMed ID: 19764837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose accuracy and injection force of disposable pens delivering pramlintide for the treatment of diabetes.
    Merritt D; Schreiner B; Harris S; DeYoung MB; Strobel S; Lauinger J
    J Diabetes Sci Technol; 2010 Nov; 4(6):1438-46. PubMed ID: 21129339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.